UGT inhibition studies in the presence or absence of alamethicin: evaluation of UGT1A1 and UGT2B7 inhibition in hlm and recombinant enzymes

被引：0
|
作者：
Ejaz, Sadaff [1 ]
Yerino, Phyllis [1 ]
Babara, Joanna [1 ]
Grbac, Robert [1 ]
Ogilvie, Brain W. [1 ]
Buckley, David B. [1 ]
机构：
[1] XenoTech LLC, Lenexa, KS USA
来源：
DRUG METABOLISM REVIEWS | 2016年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P132
引用
收藏
页码：90 / 91
页数：2
相关论文
共 50 条
  • [31] Effect of UGT1A4 and UGT2B7 polymorphism on lamotrigine metabolism during pregnancy
    Petrenaite, V.
    Ohman, I.
    Ekstrom, L.
    Bertilsson, L.
    Saebye, D.
    Tomson, T.
    Sabers, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 504 - 504
  • [32] Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients
    Romero-Lorca, Alicia
    Novillo, Apolonia
    Gaibar, Maria
    Bandres, Fernando
    Fernandez-Santander, Ana
    PLOS ONE, 2015, 10 (07):
  • [33] Pharmacogenetics of UGT1A4, UGT2B7 and UGT2B15 and Their Influence on Tamoxifen Disposition in Asian Breast Cancer Patients
    Sutiman, Natalia
    Lim, Joanne Siok Liu
    Muerdter, Thomas E.
    Singh, Onkar
    Cheung, Yin Bun
    Ng, Raymond Chee Hui
    Yap, Yoon Sim
    Wong, Nan Soon
    Ang, Peter Cher Siang
    Dent, Rebecca
    Schroth, Werner
    Schwab, Matthias
    Khor, Chiea Chuen
    Chowbay, Balram
    CLINICAL PHARMACOKINETICS, 2016, 55 (10) : 1239 - 1250
  • [34] Pharmacogenetics of UGT1A4, UGT2B7 and UGT2B15 and Their Influence on Tamoxifen Disposition in Asian Breast Cancer Patients
    Natalia Sutiman
    Joanne Siok Liu Lim
    Thomas E. Muerdter
    Onkar Singh
    Yin Bun Cheung
    Raymond Chee Hui Ng
    Yoon Sim Yap
    Nan Soon Wong
    Peter Cher Siang Ang
    Rebecca Dent
    Werner Schroth
    Matthias Schwab
    Chiea Chuen Khor
    Balram Chowbay
    Clinical Pharmacokinetics, 2016, 55 : 1239 - 1250
  • [35] UGT1A1 and UGT1A3 activity and inhibition in human liver and intestinal microsomes and a recombinant UGT system under similar assay conditions using selective substrates and inhibitors
    Mullapudi, T. V. Radhakrishna
    Ravi, Punna Rao
    Thipparapu, Ganapathi
    XENOBIOTICA, 2021, 51 (11) : 1236 - 1246
  • [36] Glucuronidation of 1′-hydroxyestragole (1′-HE) by human UDP-glucuronosyltransferases UGT2B7 and UGT1A9
    Iyer, LV
    Ho, MN
    Shinn, WM
    Bradford, WW
    Tanga, MJ
    Nath, SS
    Green, CE
    TOXICOLOGICAL SCIENCES, 2003, 73 (01) : 36 - 43
  • [37] IN VITRO EVALUATION OF UDP-GLUCURONOSYLTRANSFERASE (UGT) 1A3 AND UGT2B4 INHIBITION
    Lapham, Kimberly
    Ferguson, Nicholas
    Novak, Jonathan
    Niosi, Mark
    Goosen, Theunis
    DRUG METABOLISM AND PHARMACOKINETICS, 2020, 35 (01) : S52 - S53
  • [38] In vitro glucuronidation of mycophenolic acid by human UGTs and the impact of known polymorphisms of UGT1A8, UGT1A9, and UGT2B7
    Bernard, O
    Guillemette, C
    DRUG METABOLISM REVIEWS, 2003, 35 : 53 - 53
  • [39] Evaluation of UGT protein interactions in human hepatocytes: Effect of siRNA down regulation of UGT1A9 and UGT2B7 on propofol glucuronidation in human hepatocytes
    Konopnicki, Camille M.
    Dickmann, Leslie J.
    Tracy, Jeffrey M.
    Tukey, Robert H.
    Wienkers, Larry C.
    Foti, Robert S.
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2013, 535 (02) : 143 - 149
  • [40] Association of UGT2B7 and UGT1A4 Polymorphisms with Serum Concentration of Antiepileptic Drugs in Children
    Du, Zhongliang
    Jiao, Yukun
    Shi, Lianting
    MEDICAL SCIENCE MONITOR, 2016, 22 : 4107 - 4113
12345